23,036,271
Vote Records
25,695
Companies
11,771
Funds
3,902
Managers

Home › Companies › ASCENDIS PHARMA A/S › 2023-2024

ASCENDIS PHARMA A/S 2023-2024 Proxy Voting Records

At ASCENDIS PHARMA A/S's shareholder meeting held May 30, 2024, in the 2023-2024 proxy season, 79 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,773 separate fund positions. Their filings are grouped here into 22 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. No official Form 8-K vote tally has been matched to this meeting, so this page states no certified outcome for its most widely held ballot item. On that item — Accept Financial Statements and Statutory Reports; Approve Discharge of Management and Board — the reporting funds and managers cast 100% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings. Page generated November 8, 2026.

  • 22Reported items
  • 79Asset managers
  • 2,773Fund votes
  • May 30, 2024Meeting date

Results at a glance

No official results are on file for this meeting: no Form 8-K tally (Item 5.07) from ASCENDIS PHARMA A/S has been matched to it. The figures below are the funds’ own votes from Form N-PX. They are not the meeting result, so they are not used to judge dissent.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2025-2026

Explore ASCENDIS PHARMA A/S in the interactive database Compare manager voting policies

How asset managers voted at the ASCENDIS PHARMA A/S 2023-2024 meeting

Each item below shows how the 79 asset managers that disclosed a ASCENDIS PHARMA A/S vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of ASCENDIS PHARMA A/S’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Reelect Albert Cha as Director For Two Years Term

94% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: votes by 52 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 51 asset managers voting on “Reelect Albert Cha as Director For Two Years Term” at ASCENDIS PHARMA A/S, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity4,531,6370 00For
T. Rowe Price2,699,2750 00For
JANUS INVESTMENT FUND2,294,7110 00For
Artisan1,697,815551,641 00Mixed
Capital Group2,176,8160 00For
MFS1,308,9550 00For
Invesco958,0220 00For
FRANKLIN STRATEGIC SERIES471,9740 00For
Franklin Custodian Funds300,0000 00For
Equitable185,76348,650 00Mixed
Brighthouse106,64996,150 00Mixed
BlackRock0184,725 00Against
AllianceBernstein162,5650 00For
ALGER FUNDS0159,681 00Against
American Century146,8920 00For
Aberdeen138,7910 00For
JANUS ASPEN SERIES135,3200 00For
Thrivent111,0250 00For
MassMutual109,5510 00For
AB DISCOVERY GROWTH FUND, INC.103,9600 00For
Principal100,3130 00For
BNY Mellon97,5910 00For
Victory Capital091,663 00Against
Allspring84,8240 00For
State Street29,35225,964 00Mixed

Fund voting reports, all 51 managers: 18,351,963 for, 1,183,945 against, 50,700 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 1 asset manager voting on “Reelect Albert Cha as Director For Two Years Term” at ASCENDIS PHARMA A/S, 2023-2024
Asset managerForAgainst AbstainWithheldVote
TimesSquare Capital Management, LLC489,9161,255 00For

Institutional-manager reports, all 1 managers: 489,916 for, 1,255 against.

2. Reelect Lars Holtug as Director For Two Years Term

95% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: votes by 52 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 51 asset managers voting on “Reelect Lars Holtug as Director For Two Years Term” at ASCENDIS PHARMA A/S, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity4,531,6370 00For
T. Rowe Price2,699,2750 00For
JANUS INVESTMENT FUND2,294,7110 00For
Artisan1,697,815551,641 00Mixed
Capital Group2,176,8160 00For
MFS1,308,9550 00For
Invesco958,0220 00For
FRANKLIN STRATEGIC SERIES471,9740 00For
Franklin Custodian Funds300,0000 00For
Equitable185,76348,650 00Mixed
Brighthouse106,64996,150 00Mixed
BlackRock0184,725 00Against
AllianceBernstein162,5650 00For
ALGER FUNDS159,6810 00For
American Century146,8920 00For
Aberdeen138,7910 00For
JANUS ASPEN SERIES135,3200 00For
Thrivent111,0250 00For
MassMutual109,5510 00For
AB DISCOVERY GROWTH FUND, INC.103,9600 00For
Principal100,3130 00For
BNY Mellon97,5910 00For
Victory Capital91,6630 00For
Allspring84,8240 00For
State Street29,35225,964 00Mixed

Fund voting reports, all 51 managers: 18,658,958 for, 927,650 against. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 1 asset manager voting on “Reelect Lars Holtug as Director For Two Years Term” at ASCENDIS PHARMA A/S, 2023-2024
Asset managerForAgainst AbstainWithheldVote
TimesSquare Capital Management, LLC491,1710 00For

Institutional-manager reports, all 1 managers: 491,171 for.

3. Board of Directors proposes that the existing structure with two classes of members of the Board of Directors is…

No official resultsCORPORATE GOVERNANCE

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 28 asset managers

Description as filed by funds: The Board of Directors proposes that the existing structure with two classes of members of the Board of Directors is discontinued and is replaced with a simpler structure under which all members of the board of directors are elected for one year and are up for election at each annual general meeting in accordance with the Recommendations on Corporate Governance issued by the Danis Committee on Corporate Governance.

The 28 asset managers below reported 9,136,549 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 9,136,549
Largest asset managers voting on “The Board of Directors proposes that the existing structure with two classes of members of the Board of Direct” at ASCENDIS PHARMA A/S, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Putnam4,540,7050 00For
Vanguard2,131,1450 00For
Bridge Builder Trust502,2820 00For
HARBOR FUNDS469,1450 00For
Manager Directed Portfolios326,3580 00For
TOUCHSTONE STRATEGIC TRUST286,1030 00For
Jackson National199,3410 00For
Brown Advisory Funds179,6490 00For
Mercer Funds130,0080 00For
AMG FUNDS122,4000 00For
Hartford46,8430 00For
John Hancock40,9970 00For
Harbor Funds II34,4510 00For
Altium Capital Management LP25,0000 00For
Harbor ETF Trust20,4430 00For
Nationwide14,4600 00For
Innovator ETFs Trust13,5480 00For
SEI12,8140 00For
Brighthouse12,0250 00For
Tema ETF Trust11,7180 00For
Guardian Variable Products Trust8,4900 00For
Russell Investments3,2080 00For
BAILLIE GIFFORD FUNDS3,2020 00For
TRUST FOR PROFESSIONAL MANAGERS8790 00For
Forethought Variable Insurance Trust6410 00For

Showing the 25 largest of 28 asset managers. All 28 are in the interactive database (link above).

4. Election of attorney-at-law Lars Lüthjohan as chairman of the general meeting.

No official resultsCORPORATE GOVERNANCE

Combines 2 wordings of this item as funds reported it.

100% of fund votes cast · no official result

FOR
Details: votes by 27 asset managers

The 27 asset managers below reported 8,631,149 for, 3,118 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 8,631,149ABSTAIN: 3,118
Largest asset managers voting on “Election of attorney-at-law Lars Lüthjohan as chairman of the general meeting.” at ASCENDIS PHARMA A/S, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Putnam4,540,7050 00For
Vanguard2,131,1450 00For
HARBOR FUNDS469,1450 00For
Manager Directed Portfolios326,3580 00For
TOUCHSTONE STRATEGIC TRUST286,1030 00For
Jackson National199,3410 00For
Brown Advisory Funds179,6490 00For
Mercer Funds130,0080 00For
AMG FUNDS122,4000 00For
Hartford46,8430 00For
John Hancock40,9970 00For
Harbor Funds II34,4510 00For
Altium Capital Management LP25,0000 00For
Harbor ETF Trust20,4430 00For
Nationwide14,4600 00For
Innovator ETFs Trust13,5480 00For
SEI12,8140 00For
Brighthouse8,9070 3,1180Mixed
Tema ETF Trust11,7180 00For
Guardian Variable Products Trust8,4900 00For
Russell Investments3,2080 00For
BAILLIE GIFFORD FUNDS3,2020 00For
TRUST FOR PROFESSIONAL MANAGERS8790 00For
Forethought Variable Insurance Trust6410 00For
Victory Capital4820 00For

Showing the 25 largest of 27 asset managers. All 27 are in the interactive database (link above).

5. Election of Board Member: Albert Cha (re-election for Class II)

65% Fund and manager reports combined; may count the same shares twice · no official result

FORAGAINST
Details: votes by 18 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 17 asset managers voting on “Election of Board Member: Albert Cha (re-election for Class II)” at ASCENDIS PHARMA A/S, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Bridge Builder Trust502,2820 00For
HARBOR FUNDS8,875460,270 00Against
Manager Directed Portfolios326,3580 00For
TOUCHSTONE STRATEGIC TRUST0286,103 00Against
Jackson National199,3410 00For
Brown Advisory Funds179,6490 00For
AMG FUNDS122,4000 00For
John Hancock40,9970 00For
Harbor Funds II34,4510 00For
Harbor ETF Trust3,86716,576 00Mixed
Innovator ETFs Trust013,548 00Against
Tema ETF Trust11,7180 00For
Guardian Variable Products Trust8,4900 00For
BAILLIE GIFFORD FUNDS3,2020 00For
TRUST FOR PROFESSIONAL MANAGERS8790 00For
REYNOLDS FUNDS INC2000 00For
CITY NATIONAL ROCHDALE FUNDS120 00For

Fund voting reports, all 17 managers: 1,442,721 for, 776,497 against.

Institutional-manager reports: 1 asset manager voting on “Election of Board Member: Albert Cha (re-election for Class II)” at ASCENDIS PHARMA A/S, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Altium Capital Management LP25,0000 00For

Institutional-manager reports, all 1 managers: 25,000 for.

6. Election of Board Member: Lars Holtug (re-election for Class II)

66% Fund and manager reports combined; may count the same shares twice · no official result

FORAGAINST
Details: votes by 18 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 17 asset managers voting on “Election of Board Member: Lars Holtug (re-election for Class II)” at ASCENDIS PHARMA A/S, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Bridge Builder Trust502,2820 00For
HARBOR FUNDS8,875460,270 00Against
Manager Directed Portfolios326,3580 00For
TOUCHSTONE STRATEGIC TRUST0286,103 00Against
Jackson National199,3410 00For
Brown Advisory Funds179,6490 00For
AMG FUNDS122,4000 00For
John Hancock40,9970 00For
Harbor Funds II34,4510 00For
Harbor ETF Trust3,86716,576 00Mixed
Innovator ETFs Trust13,5480 00For
Tema ETF Trust11,7180 00For
Guardian Variable Products Trust8,4900 00For
BAILLIE GIFFORD FUNDS3,2020 00For
TRUST FOR PROFESSIONAL MANAGERS8790 00For
REYNOLDS FUNDS INC2000 00For
CITY NATIONAL ROCHDALE FUNDS120 00For

Fund voting reports, all 17 managers: 1,456,269 for, 762,949 against.

Institutional-manager reports: 1 asset manager voting on “Election of Board Member: Lars Holtug (re-election for Class II)” at ASCENDIS PHARMA A/S, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Altium Capital Management LP25,0000 00For

Institutional-manager reports, all 1 managers: 25,000 for.

7. Election of Board Members: Albert Cha (re-election for Class II)

No official resultsDIRECTOR ELECTIONS

99% of fund votes cast · no official result

FOR
Details: votes by 10 asset managers

The 10 asset managers below reported 6,811,175 for, 78,038 against, 3,118 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 6,811,175AGAINST: 78,038ABSTAIN: 3,118
Largest asset managers voting on “Election of Board Members: Albert Cha (re-election for Class II)” at ASCENDIS PHARMA A/S, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Putnam4,540,7050 00For
Vanguard2,131,1450 00For
Mercer Funds51,97078,038 00Mixed
Hartford46,8430 00For
Nationwide14,4600 00For
SEI12,8140 00For
Brighthouse8,9070 3,1180Mixed
Russell Investments3,2080 00For
Forethought Variable Insurance Trust6410 00For
Victory Capital4820 00For

8. Election of Board Members: Lars Holtug (re-election for Class II)

No official resultsDIRECTOR ELECTIONS

99% of fund votes cast · no official result

FOR
Details: votes by 10 asset managers

The 10 asset managers below reported 6,811,175 for, 78,038 against, 3,118 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 6,811,175AGAINST: 78,038ABSTAIN: 3,118
Largest asset managers voting on “Election of Board Members: Lars Holtug (re-election for Class II)” at ASCENDIS PHARMA A/S, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Putnam4,540,7050 00For
Vanguard2,131,1450 00For
Mercer Funds51,97078,038 00Mixed
Hartford46,8430 00For
Nationwide14,4600 00For
SEI12,8140 00For
Brighthouse8,9070 3,1180Mixed
Russell Investments3,2080 00For
Forethought Variable Insurance Trust6410 00For
Victory Capital4820 00For

9. Amend Articles Re: Board-Related

100% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: votes by 52 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 51 asset managers voting on “Amend Articles Re: Board-Related” at ASCENDIS PHARMA A/S, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity4,531,6370 00For
T. Rowe Price2,699,2750 00For
JANUS INVESTMENT FUND2,294,7110 00For
Artisan2,249,4560 00For
Capital Group2,176,8160 00For
MFS1,308,9550 00For
Invesco958,0220 00For
FRANKLIN STRATEGIC SERIES471,9740 00For
Franklin Custodian Funds300,0000 00For
Equitable234,4130 00For
Brighthouse202,7990 00For
BlackRock184,7250 00For
AllianceBernstein162,5650 00For
ALGER FUNDS159,6810 00For
American Century146,8920 00For
Aberdeen138,7910 00For
JANUS ASPEN SERIES135,3200 00For
Thrivent111,0250 00For
MassMutual109,5510 00For
AB DISCOVERY GROWTH FUND, INC.103,9600 00For
Principal100,3130 00For
BNY Mellon97,5910 00For
Victory Capital91,6630 00For
Allspring84,8240 00For
State Street55,3160 00For

Fund voting reports, all 51 managers: 19,586,608 for. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 1 asset manager voting on “Amend Articles Re: Board-Related” at ASCENDIS PHARMA A/S, 2023-2024
Asset managerForAgainst AbstainWithheldVote
TimesSquare Capital Management, LLC491,1710 00For

Institutional-manager reports, all 1 managers: 491,171 for.

10. Board of Directors proposes to amend the Articles of Association by adopting an authorization to the Board of Directors…

Combines 3 wordings of this item as funds reported it.

97% of fund votes cast · no official result

FOR
Details: description as filed, votes by 30 asset managers

Description as filed by funds: The Board of Directors proposes to amend the Articles of Association by adopting an authorization to the Board of Directors during the period until 29 May 2029 to issue up to 1,000,000 warrants to executive management and employees, advisors and consultants. The exercise price for the warrants shall at least be equal to the market price of the shares at the time of issuance.

The 30 asset managers below reported 8,785,877 for, 316,664 against, 92,041 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 8,785,877AGAINST: 316,664ABSTAIN: 92,041
Largest asset managers voting on “The Board of Directors proposes to amend the Articles of Association by adopting an authorization to the Board” at ASCENDIS PHARMA A/S, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Putnam4,540,7050 00For
Vanguard2,131,1450 00For
Bridge Builder Trust417,23785,045 00Mixed
HARBOR FUNDS469,1450 00For
Manager Directed Portfolios326,3580 00For
TOUCHSTONE STRATEGIC TRUST286,1030 00For
Jackson National107,3000 92,0410Mixed
Brown Advisory Funds0179,649 00Against
Mercer Funds78,03851,970 00Mixed
AMG FUNDS122,4000 00For
Saturn V Capital Management LP57,9850 00For
Hartford46,8430 00For
John Hancock40,9970 00For
Harbor Funds II34,4510 00For
Altium Capital Management LP25,0000 00For
Harbor ETF Trust20,4430 00For
Nationwide14,4600 00For
Innovator ETFs Trust13,5480 00For
SEI12,8140 00For
Brighthouse12,0250 00For
Tema ETF Trust11,7180 00For
Guardian Variable Products Trust8,4900 00For
Russell Investments3,2080 00For
BAILLIE GIFFORD FUNDS3,2020 00For
TRUST FOR PROFESSIONAL MANAGERS8790 00For

Showing the 25 largest of 30 asset managers. All 30 are in the interactive database (link above).

11. Approve Company Activity Report

100% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: votes by 52 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 51 asset managers voting on “Approve Company Activity Report” at ASCENDIS PHARMA A/S, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity4,531,6370 00For
T. Rowe Price2,699,2750 00For
JANUS INVESTMENT FUND2,294,7110 00For
Artisan2,249,4560 00For
Capital Group2,176,8160 00For
MFS1,308,9550 00For
Invesco958,0220 00For
FRANKLIN STRATEGIC SERIES471,9740 00For
Franklin Custodian Funds300,0000 00For
Equitable234,4130 00For
Brighthouse202,7990 00For
BlackRock184,7250 00For
AllianceBernstein162,5650 00For
ALGER FUNDS159,6810 00For
American Century146,8920 00For
Aberdeen138,7910 00For
JANUS ASPEN SERIES135,3200 00For
Thrivent111,0250 00For
MassMutual109,5510 00For
AB DISCOVERY GROWTH FUND, INC.103,9600 00For
Principal100,3130 00For
BNY Mellon97,5910 00For
Victory Capital91,6630 00For
Allspring84,8240 00For
State Street55,3160 00For

Fund voting reports, all 51 managers: 19,586,608 for. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 1 asset manager voting on “Approve Company Activity Report” at ASCENDIS PHARMA A/S, 2023-2024
Asset managerForAgainst AbstainWithheldVote
TimesSquare Capital Management, LLC491,1710 00For

Institutional-manager reports, all 1 managers: 491,171 for.

12. Report on the Company's Activities during the past year.

No official resultsCORPORATE GOVERNANCE

Combines 2 wordings of this item as funds reported it.

100% of fund votes cast · no official result

FOR
Details: votes by 28 asset managers

The 28 asset managers below reported 9,133,431 for, 3,118 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 9,133,431ABSTAIN: 3,118
Largest asset managers voting on “Report on the Company's Activities during the past year.” at ASCENDIS PHARMA A/S, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Putnam4,540,7050 00For
Vanguard2,131,1450 00For
Bridge Builder Trust502,2820 00For
HARBOR FUNDS469,1450 00For
Manager Directed Portfolios326,3580 00For
TOUCHSTONE STRATEGIC TRUST286,1030 00For
Jackson National199,3410 00For
Brown Advisory Funds179,6490 00For
Mercer Funds130,0080 00For
AMG FUNDS122,4000 00For
Hartford46,8430 00For
John Hancock40,9970 00For
Harbor Funds II34,4510 00For
Altium Capital Management LP25,0000 00For
Harbor ETF Trust20,4430 00For
Nationwide14,4600 00For
Innovator ETFs Trust13,5480 00For
SEI12,8140 00For
Brighthouse8,9070 3,1180Mixed
Tema ETF Trust11,7180 00For
Guardian Variable Products Trust8,4900 00For
Russell Investments3,2080 00For
BAILLIE GIFFORD FUNDS3,2020 00For
TRUST FOR PROFESSIONAL MANAGERS8790 00For
Forethought Variable Insurance Trust6410 00For

Showing the 25 largest of 28 asset managers. All 28 are in the interactive database (link above).

13. Approve Creation of DKK 9 Million Pool of Capital with Preemptive Rights

100% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: votes by 52 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 51 asset managers voting on “Approve Creation of DKK 9 Million Pool of Capital with Preemptive Rights” at ASCENDIS PHARMA A/S, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity4,531,6370 00For
T. Rowe Price2,699,2750 00For
JANUS INVESTMENT FUND2,294,7110 00For
Artisan2,249,4560 00For
Capital Group2,176,8160 00For
MFS1,308,9550 00For
Invesco958,0220 00For
FRANKLIN STRATEGIC SERIES471,9740 00For
Franklin Custodian Funds300,0000 00For
Equitable234,4130 00For
Brighthouse202,7990 00For
BlackRock184,7250 00For
AllianceBernstein162,5650 00For
ALGER FUNDS159,6810 00For
American Century146,8920 00For
Aberdeen138,7910 00For
JANUS ASPEN SERIES135,3200 00For
Thrivent111,0250 00For
MassMutual109,5510 00For
AB DISCOVERY GROWTH FUND, INC.103,9600 00For
Principal100,3130 00For
BNY Mellon97,5910 00For
Victory Capital91,6630 00For
Allspring84,8240 00For
State Street55,3160 00For

Fund voting reports, all 51 managers: 19,586,608 for. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 1 asset manager voting on “Approve Creation of DKK 9 Million Pool of Capital with Preemptive Rights” at ASCENDIS PHARMA A/S, 2023-2024
Asset managerForAgainst AbstainWithheldVote
TimesSquare Capital Management, LLC491,1710 00For

Institutional-manager reports, all 1 managers: 491,171 for.

14. Approve Treatment of Net Loss

100% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: votes by 52 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 51 asset managers voting on “Approve Treatment of Net Loss” at ASCENDIS PHARMA A/S, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity4,531,6370 00For
T. Rowe Price2,699,2750 00For
JANUS INVESTMENT FUND2,294,7110 00For
Artisan2,249,4560 00For
Capital Group2,176,8160 00For
MFS1,308,9550 00For
Invesco958,0220 00For
FRANKLIN STRATEGIC SERIES471,9740 00For
Franklin Custodian Funds300,0000 00For
Equitable234,4130 00For
Brighthouse202,7990 00For
BlackRock184,7250 00For
AllianceBernstein162,5650 00For
ALGER FUNDS159,6810 00For
American Century146,8920 00For
Aberdeen138,7910 00For
JANUS ASPEN SERIES135,3200 00For
Thrivent111,0250 00For
MassMutual109,5510 00For
AB DISCOVERY GROWTH FUND, INC.103,9600 00For
Principal100,3130 00For
BNY Mellon97,5910 00For
Victory Capital91,6630 00For
Allspring84,8240 00For
State Street55,3160 00For

Fund voting reports, all 51 managers: 19,586,608 for. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 1 asset manager voting on “Approve Treatment of Net Loss” at ASCENDIS PHARMA A/S, 2023-2024
Asset managerForAgainst AbstainWithheldVote
TimesSquare Capital Management, LLC491,1710 00For

Institutional-manager reports, all 1 managers: 491,171 for.

15. The currently existing authorization contained in article 4 d (1) to the Board of Directors to increase the Company's…

No official resultsCAPITAL STRUCTURE

Combines 2 wordings of this item as funds reported it.

99.9% of fund votes cast · no official result

FOR
Details: description as filed, votes by 28 asset managers

Description as filed by funds: The currently existing authorization contained in article 4 d (1) to the Board of Directors to increase the Company's share capital with pre-emptive subscription rights for the Company's expires 28 May 2024. The Board of Directors proposes "that a renewed authorization until 29 May 2029 is adopted."

The 28 asset managers below reported 9,133,431 for, 3,118 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 9,133,431AGAINST: 3,118
Largest asset managers voting on “The currently existing authorization contained in article 4 d (1) to the Board of Directors to increase the Co” at ASCENDIS PHARMA A/S, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Putnam4,540,7050 00For
Vanguard2,131,1450 00For
Bridge Builder Trust502,2820 00For
HARBOR FUNDS469,1450 00For
Manager Directed Portfolios326,3580 00For
TOUCHSTONE STRATEGIC TRUST286,1030 00For
Jackson National199,3410 00For
Brown Advisory Funds179,6490 00For
Mercer Funds130,0080 00For
AMG FUNDS122,4000 00For
Hartford46,8430 00For
John Hancock40,9970 00For
Harbor Funds II34,4510 00For
Altium Capital Management LP25,0000 00For
Harbor ETF Trust20,4430 00For
Nationwide14,4600 00For
Innovator ETFs Trust13,5480 00For
SEI12,8140 00For
Brighthouse8,9073,118 00Mixed
Tema ETF Trust11,7180 00For
Guardian Variable Products Trust8,4900 00For
Russell Investments3,2080 00For
BAILLIE GIFFORD FUNDS3,2020 00For
TRUST FOR PROFESSIONAL MANAGERS8790 00For
Forethought Variable Insurance Trust6410 00For

Showing the 25 largest of 28 asset managers. All 28 are in the interactive database (link above).

16. Accept Financial Statements and Statutory Reports; Approve Discharge of Management and Board

No official resultsFund totals may overlapCAPITAL STRUCTURECORPORATE GOVERNANCE

100% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: votes by 52 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 51 asset managers voting on “Accept Financial Statements and Statutory Reports; Approve Discharge of Management and Board” at ASCENDIS PHARMA A/S, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity4,531,6370 00For
T. Rowe Price2,699,2750 00For
JANUS INVESTMENT FUND2,294,7110 00For
Artisan2,249,4560 00For
Capital Group2,176,8160 00For
MFS1,308,9550 00For
Invesco958,0220 00For
FRANKLIN STRATEGIC SERIES471,9740 00For
Franklin Custodian Funds300,0000 00For
Equitable234,4130 00For
Brighthouse202,7990 00For
BlackRock184,7250 00For
AllianceBernstein162,5650 00For
ALGER FUNDS159,6810 00For
American Century146,8920 00For
Aberdeen138,7910 00For
JANUS ASPEN SERIES135,3200 00For
Thrivent111,0250 00For
MassMutual109,5510 00For
AB DISCOVERY GROWTH FUND, INC.103,9600 00For
Principal100,3130 00For
BNY Mellon97,5910 00For
Victory Capital91,6630 00For
Allspring84,8240 00For
State Street55,3160 00For

Fund voting reports, all 51 managers: 19,586,608 for. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 1 asset manager voting on “Accept Financial Statements and Statutory Reports; Approve Discharge of Management and Board” at ASCENDIS PHARMA A/S, 2023-2024
Asset managerForAgainst AbstainWithheldVote
TimesSquare Capital Management, LLC491,1710 00For

Institutional-manager reports, all 1 managers: 491,171 for.

17. Resolution on Application of Profits or Covering of Losses as per the Adopted Annual Report.

No official resultsCORPORATE GOVERNANCE

Combines 2 wordings of this item as funds reported it.

100% of fund votes cast · no official result

FOR
Details: votes by 28 asset managers

The 28 asset managers below reported 9,133,431 for, 3,118 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 9,133,431ABSTAIN: 3,118
Largest asset managers voting on “Resolution on Application of Profits or Covering of Losses as per the Adopted Annual Report.” at ASCENDIS PHARMA A/S, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Putnam4,540,7050 00For
Vanguard2,131,1450 00For
Bridge Builder Trust502,2820 00For
HARBOR FUNDS469,1450 00For
Manager Directed Portfolios326,3580 00For
TOUCHSTONE STRATEGIC TRUST286,1030 00For
Jackson National199,3410 00For
Brown Advisory Funds179,6490 00For
Mercer Funds130,0080 00For
AMG FUNDS122,4000 00For
Hartford46,8430 00For
John Hancock40,9970 00For
Harbor Funds II34,4510 00For
Altium Capital Management LP25,0000 00For
Harbor ETF Trust20,4430 00For
Nationwide14,4600 00For
Innovator ETFs Trust13,5480 00For
SEI12,8140 00For
Brighthouse8,9070 3,1180Mixed
Tema ETF Trust11,7180 00For
Guardian Variable Products Trust8,4900 00For
Russell Investments3,2080 00For
BAILLIE GIFFORD FUNDS3,2020 00For
TRUST FOR PROFESSIONAL MANAGERS8790 00For
Forethought Variable Insurance Trust6410 00For

Showing the 25 largest of 28 asset managers. All 28 are in the interactive database (link above).

18. Elect Chairman of Meeting

100% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: votes by 52 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 51 asset managers voting on “Elect Chairman of Meeting” at ASCENDIS PHARMA A/S, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity4,531,6370 00For
T. Rowe Price2,699,2750 00For
JANUS INVESTMENT FUND2,294,7110 00For
Artisan2,249,4560 00For
Capital Group2,176,8160 00For
MFS1,308,9550 00For
Invesco958,0220 00For
FRANKLIN STRATEGIC SERIES471,9740 00For
Franklin Custodian Funds300,0000 00For
Equitable234,4130 00For
Brighthouse202,7990 00For
BlackRock184,7250 00For
AllianceBernstein162,5650 00For
ALGER FUNDS159,6810 00For
American Century146,8920 00For
Aberdeen138,7910 00For
JANUS ASPEN SERIES135,3200 00For
Thrivent111,0250 00For
MassMutual109,5510 00For
AB DISCOVERY GROWTH FUND, INC.103,9600 00For
Principal100,3130 00For
BNY Mellon97,5910 00For
Victory Capital91,6630 00For
Allspring84,8240 00For
State Street55,3160 00For

Fund voting reports, all 51 managers: 19,586,608 for. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 1 asset manager voting on “Elect Chairman of Meeting” at ASCENDIS PHARMA A/S, 2023-2024
Asset managerForAgainst AbstainWithheldVote
TimesSquare Capital Management, LLC491,1710 00For

Institutional-manager reports, all 1 managers: 491,171 for.

19. Approve Warrant Plan for Key Employees

84% Fund and manager reports combined; may count the same shares twice · no official result

FORAGAINST
Details: votes by 52 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 51 asset managers voting on “Approve Warrant Plan for Key Employees” at ASCENDIS PHARMA A/S, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity4,531,212425 00For
T. Rowe Price2,678,71520,560 00For
JANUS INVESTMENT FUND2,294,7110 00For
Artisan1,697,815551,641 00Mixed
Capital Group2,176,8160 00For
MFS1,308,9550 00For
Invesco188,2000 769,8220Mixed
FRANKLIN STRATEGIC SERIES0471,974 00Against
Franklin Custodian Funds0300,000 00Against
Equitable197,58436,829 00Mixed
Brighthouse096,635 106,1640Mixed
BlackRock0184,725 00Against
AllianceBernstein0162,565 00Against
ALGER FUNDS0159,681 00Against
American Century0146,892 00Against
Aberdeen0138,791 00Against
JANUS ASPEN SERIES135,3200 00For
Thrivent0111,025 00Against
MassMutual80,2000 29,3510Mixed
AB DISCOVERY GROWTH FUND, INC.0103,960 00Against
Principal0100,313 00Against
BNY Mellon097,591 00Against
Victory Capital091,663 00Against
Allspring084,824 00Against
State Street25,96429,352 00Mixed

Fund voting reports, all 51 managers: 15,528,876 for, 3,142,819 against, 914,913 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 1 asset manager voting on “Approve Warrant Plan for Key Employees” at ASCENDIS PHARMA A/S, 2023-2024
Asset managerForAgainst AbstainWithheldVote
TimesSquare Capital Management, LLC489,9161,255 00For

Institutional-manager reports, all 1 managers: 489,916 for, 1,255 against.

20. Ratify Deloitte as Auditors

100% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: votes by 52 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 51 asset managers voting on “Ratify Deloitte as Auditors” at ASCENDIS PHARMA A/S, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity4,531,6370 00For
T. Rowe Price2,699,2750 00For
JANUS INVESTMENT FUND2,294,7110 00For
Artisan2,249,4560 00For
Capital Group2,176,8160 00For
MFS1,308,9550 00For
Invesco958,0220 00For
FRANKLIN STRATEGIC SERIES471,9740 00For
Franklin Custodian Funds300,0000 00For
Equitable234,4130 00For
Brighthouse202,7990 00For
BlackRock184,7250 00For
AllianceBernstein162,5650 00For
ALGER FUNDS159,6810 00For
American Century146,8920 00For
Aberdeen138,7910 00For
JANUS ASPEN SERIES135,3200 00For
Thrivent111,0250 00For
MassMutual109,5510 00For
AB DISCOVERY GROWTH FUND, INC.103,9600 00For
Principal100,3130 00For
BNY Mellon97,5910 00For
Victory Capital91,6630 00For
Allspring84,8240 00For
State Street55,3160 00For

Fund voting reports, all 51 managers: 19,586,608 for. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 1 asset manager voting on “Ratify Deloitte as Auditors” at ASCENDIS PHARMA A/S, 2023-2024
Asset managerForAgainst AbstainWithheldVote
TimesSquare Capital Management, LLC491,1710 00For

Institutional-manager reports, all 1 managers: 491,171 for.

21. Election of State-authorized Public Auditor.

No official resultsAUDIT-RELATED

99.8% of fund votes cast · no official result

FOR
Details: votes by 28 asset managers

The 28 asset managers below reported 9,119,883 for, 13,548 against, 3,118 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 9,119,883AGAINST: 13,548ABSTAIN: 3,118
Largest asset managers voting on “Election of State-authorized Public Auditor.” at ASCENDIS PHARMA A/S, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Putnam4,540,7050 00For
Vanguard2,131,1450 00For
Bridge Builder Trust502,2820 00For
HARBOR FUNDS469,1450 00For
Manager Directed Portfolios326,3580 00For
TOUCHSTONE STRATEGIC TRUST286,1030 00For
Jackson National199,3410 00For
Brown Advisory Funds179,6490 00For
Mercer Funds130,0080 00For
AMG FUNDS122,4000 00For
Hartford46,8430 00For
John Hancock40,9970 00For
Harbor Funds II34,4510 00For
Altium Capital Management LP25,0000 00For
Harbor ETF Trust20,4430 00For
Nationwide14,4600 00For
Innovator ETFs Trust013,548 00Against
SEI12,8140 00For
Brighthouse8,9070 3,1180Mixed
Tema ETF Trust11,7180 00For
Guardian Variable Products Trust8,4900 00For
Russell Investments3,2080 00For
BAILLIE GIFFORD FUNDS3,2020 00For
TRUST FOR PROFESSIONAL MANAGERS8790 00For
Forethought Variable Insurance Trust6410 00For

Showing the 25 largest of 28 asset managers. All 28 are in the interactive database (link above).

22. Presentation of Audited Annual Report with Auditor's Statement for Approval and Discharge of the Board of Directors and…

No official resultsAUDIT-RELATED

Combines 2 wordings of this item as funds reported it.

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 28 asset managers

Description as filed by funds: Presentation of Audited Annual Report with Auditor's Statement for Approval and Discharge of the Board of Directors and Management.

The 28 asset managers below reported 9,133,431 for, 3,118 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 9,133,431ABSTAIN: 3,118
Largest asset managers voting on “Presentation of Audited Annual Report with Auditor's Statement for Approval and Discharge of the Board of Dire” at ASCENDIS PHARMA A/S, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Putnam4,540,7050 00For
Vanguard2,131,1450 00For
Bridge Builder Trust502,2820 00For
HARBOR FUNDS469,1450 00For
Manager Directed Portfolios326,3580 00For
TOUCHSTONE STRATEGIC TRUST286,1030 00For
Jackson National199,3410 00For
Brown Advisory Funds179,6490 00For
Mercer Funds130,0080 00For
AMG FUNDS122,4000 00For
Hartford46,8430 00For
John Hancock40,9970 00For
Harbor Funds II34,4510 00For
Altium Capital Management LP25,0000 00For
Harbor ETF Trust20,4430 00For
Nationwide14,4600 00For
Innovator ETFs Trust13,5480 00For
SEI12,8140 00For
Brighthouse8,9070 3,1180Mixed
Tema ETF Trust11,7180 00For
Guardian Variable Products Trust8,4900 00For
Russell Investments3,2080 00For
BAILLIE GIFFORD FUNDS3,2020 00For
TRUST FOR PROFESSIONAL MANAGERS8790 00For
Forethought Variable Insurance Trust6410 00For

Showing the 25 largest of 28 asset managers. All 28 are in the interactive database (link above).

Largest ASCENDIS PHARMA A/S shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 57,707,439 shares outstanding at the time of that meeting.

Fund voting reports: top ASCENDIS PHARMA A/S shareholders by shares voted on “Accept Financial Statements and Statutory Reports; Approve Discharge of Management and Board”, 2023-2024
#Asset manager % of shares outstanding
1Fidelity 7.85%
2T. Rowe Price 4.68%
3JANUS INVESTMENT FUND 3.98%
4Artisan 3.90%
5Capital Group 3.77%
6MFS 2.27%
7Invesco 1.66%
8FRANKLIN STRATEGIC SERIES 0.82%
9Franklin Custodian Funds 0.52%
10Equitable 0.41%
Institutional-manager reports: top ASCENDIS PHARMA A/S shareholders by shares voted on “The Board of Directors proposes to amend the Articles of Association by adopting an…”, 2023-2024
#Asset manager % of shares outstanding
1Saturn V Capital Management LP 0.10%
2Altium Capital Management LP 0.04%
3HOLLENCREST CAPITAL MANAGEMENT <0.01%

Reported ASCENDIS PHARMA A/S holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

ASCENDIS PHARMA A/S holdings and ownership disclosed for the 2023-2024 proxy season
Holder % outstanding Disclosure
Westfield Capital Management Company, L.P. 9.58% 13G
FMR LLC 8.05% 13G
JANUS HENDERSON GROUP PLC 7.79% 13G
FMR (Fidelity) 7.75% 13F
Wellington Management 4.76% 13F
Capital International 3.80% 13F
Franklin Templeton 3.43% 13F
T. Rowe Price 3.09% 13F
Invesco 1.67% 13F
Goldman Sachs 1.15% 13F

Percentages above are of 57,707,439 shares outstanding, as reported by ASCENDIS PHARMA A/S on its Form 20-F dated December 31, 2023 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ASCENDIS PHARMA A/S’s 20-F dated December 31, 2023. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.

ASCENDIS PHARMA A/S proxy season coverage: 2023-2024 (this page) · 2025-2026.

Cite this page

proxyvotesnow.com, “ASCENDIS PHARMA A/S (ASND) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/ascendis-pharma-a-s/2024 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.